跳至主要内容
临床试验/ChiCTR1800015320
ChiCTR1800015320尚未招募Unknown

A pilot study on the association between gut microbiota and development of breast cancer in Hong Kong Chinese

香港中文大學1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2018年4月10日最近更新:
干预措施

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
600
试验地点
1
主要终点
profile of gut microbiota in hormonal receptor-positive breast cancer and controls

研究概览

简要总结

Characterize and compare the structural and functional profile of gut microbiota between women with hormonal receptor-positive breast cancer and controls

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 100(—)
性别
Female

入选标准

  • Chinese female;
  • Aged greater than or equal to 18 years (no upper age limit);
  • Either: with a newly (within 3 months without surgical intervention other than biopsy) suspected benign or malignant breast lesion(s) for which tissue sample has been/will be taken pathological diagnosis (regardless of the results);
  • OR: a bilateral mammogram / ultrasonic examination of the breast has been / will be performed within 3 months of enrollment (regardless of the results);
  • Willing to complete a questionnaire on medical history, life style and health information.
  • Willing to provide clinical findings and investigation results including pathology, radiography and ultrasonography reports related to the health status of breast.
  • Willing to donate a stool sample for this study (other optional samples include urine, blood and remaining breast tissue after completing pathological investigations).
  • Willing to provide a consent for study.

排除标准

  • Had undergone surgical removal of part or whole breast tissue (other than biopsy);
  • Had received any treatment for malignant breast lesions including surgery, radiotherapy, chemotherapy or hormonal therapy;
  • History of any cancer (not include the current suspected/confirmed breast lesion);
  • Had received antibiotics with the last 3 weeks (can postpone stool collection to 3 weeks after completing antibiotic treatment);
  • History of inflammatory bowel diseases or diverticulitis;
  • History of gastric banding or bypass;
  • History of major gastric or intestinal surgery (not include endoscopy, biopsy, removal of polyps or haemorrhoids).

研究组 & 干预措施

Control group 3:

No

干预措施: No

Case group 1:

No

Case group 2:

No

Control group 1:

Control group 4:

No

Control group 2:

No

结局指标

主要结局

profile of gut microbiota in hormonal receptor-positive breast cancer and controls

时间窗: cross-sectional at enrollment

次要结局

  • Identify the correlations between gut and breast tissue microbiota among women with different subtypes of breast cancer or benign conditions.(cross-sectional at enrollment)
  • Correlate gut microbiota with level of estrogens and estrogen metabolites in urine and blood, and with breast tissue microbiota.(cross-sectional at enrollment)

研究者

发起方
香港中文大學

研究点 (1)

Loading locations...

相似试验